Sickle Cell Disease Treatment Demonstration Program Regional Collaborative
This announcement solicits applications for the Sickle Cell Treatment Demonstration Program Regional Collaborative. The purpose of this funding opportunity is to:
(1) increase the number of providers that are treating sickle cell patients in the region; (2) increase the number of providers prescribing disease-modifying therapies, such as hydroxyrea; and (3) increase the number of sickle cell patients that are receiving care from providers with greater knowledge of how to treat sickle cell disease.
This program will use collective impact strategies (see Collective Impact below) and collaborative learning to create Sickle Cell Regional Collaboratives that develop regional and sstate infrastructure to increase the number of providers providing disease-modifying therapies and enhancing the prevention and treatment of sickle cell disease through coordination of service delivery, genetic counseling and testing, bundling of technical services, training of health professionals, and efforts related to the expansion and coordination of education, treatment, and continuity of care for individuals with sickle cell disease.
(1) increase the number of providers that are treating sickle cell patients in the region; (2) increase the number of providers prescribing disease-modifying therapies, such as hydroxyrea; and (3) increase the number of sickle cell patients that are receiving care from providers with greater knowledge of how to treat sickle cell disease.
This program will use collective impact strategies (see Collective Impact below) and collaborative learning to create Sickle Cell Regional Collaboratives that develop regional and sstate infrastructure to increase the number of providers providing disease-modifying therapies and enhancing the prevention and treatment of sickle cell disease through coordination of service delivery, genetic counseling and testing, bundling of technical services, training of health professionals, and efforts related to the expansion and coordination of education, treatment, and continuity of care for individuals with sickle cell disease.
Agency: Department of Health and Human Services
Office: Health Resources and Services Administration
Estimated Funding: $3,400,000
Office: Health Resources and Services Administration
Estimated Funding: $3,400,000
Obtain Full Opportunity Text:
Not Available
Additional Information of Eligibility:
Eligible entities for this cooperative agreement program are any Federally-qualified health center, nonprofit hospital or clinic, or university health center that provides primary health care that: (1) has a collaborative agreement with a community-based sickle cell disease organization or a nonprofit entity with experience in working with individuals with sickle cell disease; and (2) demonstrates that it, the collaborative entity, or the experts described in section 712(c)(2)(C) of the American Jobs Creation Act of 2004, has at least five (5) years¿ experience working with individuals who have sickle cell disease.
Faith-based and community-based organizations that meet these qualifications are eligible.
Full Opportunity Web Address:
Contact:
Department of Health and Human Services, Health Resources and Services Administration, HRSA Grants Application Center, 910 Clopper Road, Suite 155 South, Gaithersburg, MD, 20878CallCenter@HRSA.GOV
Agency Email Description:
Contact HRSA Call Center at 877-Go4-HRSA/877-464-4772 or email CallCenter@HRSA.GOV
Agency Email:
CallCenter@HRSA.GOV
Date Posted:
2014-04-24
Application Due Date:
2014-05-27
Archive Date:
2014-07-26
Social Entrepreneurship
Spotlight
The Social Innovators of 2014
For 2014, the Schwab Foundation for Social Entrepreneurship has recognized 37 individuals for their outstanding work in the field of social enterprise.
Learn How to Identify and Avoid Grant Scams
